TriSalus Life Sciences, Inc. TLSI Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s total liabilities?
- TriSalus Life Sciences, Inc. (TLSI) reported total liabilities of $58.17M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total liabilities changed year-over-year?
- TriSalus Life Sciences, Inc.'s total liabilities decreased by 7.7% year-over-year, from $63M to $58.17M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), TriSalus Life Sciences, Inc.'s total liabilities has grown at a 24.1% compound annual growth rate (CAGR), from $23.5M to $69.19M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.